Trials / Unknown
UnknownNCT01561222
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Taixing People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol | 0.25 ug per day for one year |
| DRUG | placebo | one pill per day |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-03-01
- First posted
- 2012-03-22
- Last updated
- 2015-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01561222. Inclusion in this directory is not an endorsement.